Ubamatamab (Anti-CA125 & CD3)
Product Specifications
CAS Number
2305629-50-7
Synonyms
REGN4018
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Ubamatamab is a bispecific IgG4-based antibody targeting MUC16 on tumor cells and CD3 on T cells to enhance immune activation. It is designed for the treatment of ovarian cancer by recruiting T cells for MUC16-directed tumor cell killing with reduced Fcγ receptor affinity. M.W 144.64 kDa
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC432079 20 µg
EIF4ENIF1 (NM_001164501) Human Over-expression Lysate
Sign In for Pricing
View Details